Cargando…
Long-term safety of filgrastim (rhG-CSF) administration
Autores principales: | Confer, Dennis L, Miller, John P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1920544/ https://www.ncbi.nlm.nih.gov/pubmed/17359373 http://dx.doi.org/10.1111/j.1365-2141.2007.06524.x |
Ejemplares similares
-
Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients
por: Jiang, Yantao, et al.
Publicado: (2023) -
rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy
por: Wang, Yong, et al.
Publicado: (2022) -
Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer
por: Li, Weiwei, et al.
Publicado: (2023) -
Antitumoral effect of maintained neutrophilia induced by rhG-CSF in a murine model of pancreatic cancer
por: Brú, A., et al.
Publicado: (2019) -
Radioprotective effects of Sipunculus nudus L. polysaccharide combined with WR-2721, rhIL-11 and rhG-CSF on radiation-injured mice
por: Jiang, Shuqi, et al.
Publicado: (2015)